FDA Recalls Batches of Levothyroxine Sodium Due to Potential Quality Issues

The U.S. Food and Drug Administration (FDA) has ordered the recall of specific batches of levothyroxine sodium, a medication used to treat hypothyroidism and other thyroid conditions. The recall stems from quality control issues that could affect the drug's potency or stability, potentially leading to altered disease control and symptoms related to thyroid dysfunction, such as fatigue, changes in heart rhythm, or weight fluctuations. Patients are advised to consult their healthcare providers regarding their medication.